Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Transoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck Cancer

NCT03281499 · University Health Network, Toronto · Updated 1 Aug 2023

What is being tested
da Vinci Surgical System Model IS4000
For
Head and Neck Squamous Cell Carcinoma
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 22 people. The full rules are on the registry page.
Where
Canada
When
Starts or started 15 Aug 2017, ends 19 July 2022. Registered 13 Sept 2017.
Results
None posted yet.

In the researchers' words

The purpose of this study is to evaluate the use of Transoral Robotic Surgery (TORS) to identify small oropharyngeal carcinomas. Findings from this study will be used to better determine which patients may be suitable for more targeted radiotherapy that would lead to a reduction in the total amount of radiotherapy needed as part of their treatment. Reducing the amount of radiotherapy received has been found to reduce the risk of late complications and toxicity to the patient.The pathologic findings will then be used to determine patients who may be candidates for de-intensification of radiotherapy.
ClinicalTrials.gov, NCT03281499

Sites

  • Princess Margaret Cancer CentreToronto, Ontario, Canada